Gate2Brain
  • Home
  • Company
  • Team
  • Technology
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Meritxell Teixidó (Gate2Brain, Medicines Beyond Barriers): “We use a new technology based on peptides to improve the transport of drugs to the brain”

News
Meritxell Teixidó (Gate2Brain, Medicines Beyond Barriers): “Utilitzem una nova tecnologia basada en pèptids per millorar el transport de fàrmacs al cervell”

Meritxell Teixidó (Gate2Brain, Medicines Beyond Barriers): “Utilitzem una nova tecnologia basada en pèptids per millorar el transport de fàrmacs al cervell”

Academy for Women Entrepreneurs (AWE) és un programa de Foment del Treball, el Departament d’Estat d’Estats Units i el Consolat Americà en el qual han pogut participar 30 dones emprenedores. L’AWE consta de 4 eixos: formació en línia per part de l’Escola de negocis Thunderbird de la Universitat d’Arizona, Masterclasses presencials, sessions inspiradores i l’oportunitat de formar part de la xarxa global AWE amb connexions a tot el món.

 

Avui parlem amb Meritxell Teixidó, CEO& CSO, “Gate2Brain, Medicines Beyond Barriers”.

Quin projecte vas presentar per poder formar part del programa AWE?

Vaig presentar Gate2Brain, la jove empresa biotecnològica que vaig fundar el juliol de 2020. Gate2Brain és una empresa que utilitza una nova tecnologia basada en pèptids per millorar el transport de fàrmacs al cervell i que té com a primera indicació el transport d’un agent quimioterapèutic al cervell per tractar tumors cerebrals pediàtrics.

Dels quatre eixos del programa, quin és el que més t’ha ajudat a tirar endavant el teu projecte?

Les sessions de propietat intel·lectual, acords de llicència i pacte de socis amb RCD han estat especialment útils per a nosaltres. Especialment rellevant en ser una jove empresa i estar fora de la nostra zona de confort.

Com t’ha ajudat Foment a fer créixer la teva idea/projecte?

Sobretot a nivell de visibilitat i  de networking  amb les dones emprenedores AWE a Catalunya. Compartint reptes, estratègies i aprenentatges juntes.

Quins són els reptes de futur més immediats per al teu projecte?

Aconseguir una ronda d’inversió. Recentment hem obert una ronda pont de 1 M€ i  volem obrir una ronda sèrie A de 6 M€ el Q3 de 2022.

Quin missatge donaries a les dones emprenedores que tenen una idea però tenen dubtes de posar-la en marxa?

El meu missatge seria que  es llencin a tirar-ho endavant  amb passió i busquin entorns on puguin créixer junt amb altres emprenedors/es.

 

Font: https://larevista.foment.com/2021/12/09/meritxell-teixido-gate2brain-medicines-beyond-barriers-utilitzem-una-nova-tecnologia-basada-en-peptids-per-millorar-el-transport-de-farmacs-al-cervell/

December 9, 2021/by noticias
Tags: AWE, Foment del Treball, Startup, Women Entrepreneurs
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2021/12/Captura-de-pantalla-2021-12-13-a-las-9.51.07.png 1108 1392 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2021-12-09 09:10:462021-12-13 09:53:07Meritxell Teixidó (Gate2Brain, Medicines Beyond Barriers): “We use a new technology based on peptides to improve the transport of drugs to the brain”
You might also like
THIS IS HOW A DRUG IS TOWED TO THE BRAINExpansión THIS IS HOW A DRUG IS TOWED TO THE BRAIN
Foment shows how the leadership of a new generation of female innovators is already a reality at # MWC21Foment del Treball Foment shows how the leadership of a new generation of female innovators is already a reality at # MWC21
la start-up catalana una de las ganadoras del South Summit de salud en Valenciala Vanguardia Gate2Brain one of the winners of the South Summit Health & Well-being
CaixaImpuls Gate2Brain as alumni at Caixa Impulse Validate
desafio singaporeICEX Desafía Singapore
talento científicotalento cientifico Founding a company in times of pandemic
BioSpain2021 Gate2Brain attending BioSpain 2021
Many drugs do not reach the brain and Gate2Brain technology helps to overcome that bottleneck

CATEGORIES

  • Clipping
  • Events
  • News
  • Podcast
  • Press releases
  • Publications
  • Videos

Events

  • 📢 On December 13h, Gate2Brain will be participating together with Maribel Berges (AFFIRMA BIOTECH SL), Sven Dr. Mulfinger (Dana_positive maternal health), and Diana Ballart (The Smart Lollipop) in the i4kids Closing Event 2022, sharing achievements and failures of entrepreneurs in #pediatric and maternal #healthcare.i4kidsi4kids Closing Event 2022December 7, 2022 - 12:37
  • WomenStartupAwards, in the "Inspiration" category.WomeninTechSpainFinalist of Women Startup AwardsNovember 15, 2022 - 17:46
  • GORDON CONFERENCESgate2brainGordon Research ConferencesNovember 3, 2022 - 11:41
  • Gate2Brain's retreat 2022Gate2BrainGate2Brain’s retreat 2022October 24, 2022 - 19:27
  • BIO EUROPE 2022GATE2BRAINGate2Brain at BIO-EUROPE 2022September 22, 2022 - 13:39

SOCIAL

  • linkedin
  • youtube

RSS RSS Ciencia

  • What will the d·Health Barcelona Part Time program clinical immersion be like? January 24, 2023 biocat
  • Good start to the year in investment and advances in projects at science facilities January 24, 2023 biocat
  • AseBio and Biocat present BIOSPAIN 2023 in Barcelona to over 200 people from the sector January 16, 2023 biocat
  • 2022: Healthcare research and innovation are strategic priorities for Catalonia December 23, 2022 biocat
  • 5th edition of CRAASH Barcelona program comes to an end December 21, 2022 biocat
  • Registration now open for presentation of 2022 BioRegion Report December 20, 2022 biocat
  • Open Innovation Forum consolidates role resolving innovation challenges in BioRegion December 20, 2022 biocat
  • AseBio and Biocat to present BIOSPAIN 2023 in Barcelona at public event open to whole ecosystem December 12, 2022 biocat
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
TedxSitges 2021 Leaders beyond barriers Líderes que van más allá de las barrerasTedxSitges Gate2Brain among the 11 most promising life & health sciences startups...
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}